Garmin® Health and ActiGraph™ collaborate on wearable solutions for clinical trials
December 12 2018 - 7:00AM
Business Wire
Garmin International, Inc., a unit of Garmin Ltd. (NASDAQ:
GRMN), today announced a collaboration with ActiGraph to explore
creation of innovative health and activity monitoring solutions
that would utilize Garmin wearables and ActiGraph‘s CentrePoint
data analytics platform for academic research, clinical trials, and
remote patient monitoring.
ActiGraph, a global leader in medical-grade activity and sleep
monitoring solutions for the scientific community, provides
wearable accelerometry monitors and a robust software technology
platform that together form the most comprehensive data monitoring,
analysis, and management solution in the industry. Considered the
gold standard in objective, physical activity measurement,
ActiGraph monitors are the most widely used and extensively
validated devices of their kind, with clients at more than 1,500
pharmaceutical, academic, and scientific institutions in over 85
countries.
“Garmin Health is excited to work with a globally recognized
company like ActiGraph that shares an engineering commitment to
pioneer high-quality solutions that can be trusted by the
scientific community and pharmaceutical market,” said Travis
Johnson, Garmin Health global product lead. “Combining the sensor
data from Garmin wearables with the data capture and analytical
expertise of the ActiGraph platform creates a powerful solution for
many different patient monitoring applications.”
“ActiGraph is excited to work with an innovative company like
Garmin,” said Jeremy Wyatt, ActiGraph chief technology officer and
senior vice president of product development. “Garmin wearables
produce high-resolution, accurate data streams that are ideal for
scientific analysis and can provide additional, novel endpoints to
the ActiGraph software platform. What’s more, the long battery life
and ergonomic design of Garmin’s wearables means study participants
can comfortably wear the devices for extended periods, leading to
improved program adherence and study results.”
The future of wearables as important health and medical tools is
rapidly evolving. Garmin is committed to the development of
wearables that can lead to the detection of serious health
conditions, and they also play an important role in the development
of both traditional and digital therapeutics. Collaborating with
ActiGraph on solutions for researchers will accelerate these
developments and ultimately improve health outcomes and everyday
life for many people.
The ever-expanding Garmin fitness segment develops technologies
to enhance and promote healthy and active lifestyles. Garmin Health
provides enterprise solutions that leverage Garmin wearables and
the high-quality sensor data they produce for applications in the
corporate wellness, population health, and patient monitoring
markets.
About Garmin International, Inc.
Garmin International, Inc., is a subsidiary of Garmin Ltd.
(Nasdaq: GRMN). Garmin Ltd. is incorporated in Switzerland, and its
principal subsidiaries are located in the United States, Taiwan and
the United Kingdom. Garmin is registered trademarks of Garmin Ltd.
All rights reserved.
About ActiGraph
ActiGraph is a leading provider of medical-grade physical
activity and sleep monitoring solutions for the global scientific
community. ActiGraph’s wearable actigraphy monitors and robust
analytics platform have been widely used to quantify human movement
in academic and population health research for nearly two decades.
In recent years, the company’s monitoring solutions have been
steadily adopted by biopharma and life sciences organizations
seeking to capture real-world objective outcomes related to
physical activity, mobility, and sleep behavior for patients
enrolled in clinical trials.
Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding
Garmin Ltd. and its business. Such statements are based on
management’s current expectations. The forward-looking events and
circumstances discussed in this release may not occur and actual
results could differ materially as a result of known and unknown
risk factors and uncertainties affecting Garmin, including, but not
limited to, the risk factors listed in the Annual Report on Form
10-K for the year ended December 30, 2017, filed by Garmin with the
Securities and Exchange Commission (Commission file number
0-31983). A copy of such Form 10-K is available at
http://www.garmin.com/aboutGarmin/invRelations/finReports.html. No
forward-looking statement can be guaranteed. Forward-looking
statements speak only as of the date on which they are made and
Garmin undertakes no obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181212005011/en/
Garmin International Inc.Carly
Hysell913/397-8200media.relations@garmin.com
Garmin (NASDAQ:GRMN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Garmin (NASDAQ:GRMN)
Historical Stock Chart
From Apr 2023 to Apr 2024